Hemolysis
46
5
5
26
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.5%
3 terminated out of 46 trials
89.7%
+3.1% vs benchmark
2%
1 trials in Phase 3/4
12%
3 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (46)
Feasibility Performance Study of ABL90 FLEX PLUS HEM
Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
CPB Prime Fluid Strategies to Preserve Mcirocirculatory Perfusion
Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With Dogs
Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in Hemodialysis
Electric Polarization of Red Blood Cells : A Cohort Study to Assess the Erythrocytes Membrane Integrity Through Charge Conservation, Following Cardiac Surgery.
Sildenafil To Prevent Clot
Biodex Training in Hemodialysis Females With Osteopenia
Diet Therapy in Hemodialysis Patients
Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury
The Effect of Coolsense Method on Pain and Comfort in Hemodialysis Patients
Hemolysis During Pulsed-field and Radiofrequency Ablation
The Effect Of Vıdeo-Based Fıstula Care Educatıon On Hemodıalysıs
Dietary Fiber and Hyperkalemia in Dialysis Patients
Optimization of Prime Fluid Strategy to Preserve Microcirculatory Perfusion During Cardiac Surgery With Cardiopulmonary Bypass, Part II
Laughter Therapy Application in Hemodialysis Patients
Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device
A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNH
Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population